Ignite Creation Date:
2025-12-24 @ 12:06 PM
Ignite Modification Date:
2026-01-31 @ 10:30 PM
Study NCT ID:
NCT00462761
Status:
COMPLETED
Last Update Posted:
2020-05-11
First Post:
2007-04-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status
Sponsor:
Daiichi Sankyo
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | RTK | View |
| None | kinase | View |
| None | inhibitor | View |
| None | tyrosine | View |
| None | acute | View |
| None | FLT3 | View |
| None | AC220 | View |
| None | pharmacokinetic | View |
| None | pharmacokinetics | View |
| None | PK | View |
| None | pharmacodynamic | View |
| None | pharmacodynamics | View |
| None | mutations | View |
| None | PD | View |
| None | receptor | View |
| None | class III | View |
| None | relapsed | View |
| None | refractory | View |
| None | t(8;21) | View |
| None | q22;q22 | View |
| None | AML1/ETO | View |
| None | t(16;16 | View |
| None | p13;q22 | View |
| None | CBFbeta/MYH11 | View |
| None | inv(16) | View |
| None | p13q22 | View |
| None | 11q23 | View |
| None | dysplasia | View |
| None | myeloid | View |
| None | myelomonocytic | View |
| None | monoblastic | View |
| None | monocytic | View |
| None | erythroid | View |
| None | erythroleukemia | View |
| None | megakaryoblastic | View |
| None | basophilic | View |
| None | panmyelosis | View |
| None | myelofibrosis | View |